Logo image of EXTN

Exterran Corporation (EXTN) Stock Fundamental Analysis

NYSE:EXTN - New York Stock Exchange, Inc. - US30227H1068 - Common Stock - Currency: USD

4.58  -0.26 (-5.37%)

After market: 4.66 +0.08 (+1.75%)

Fundamental Rating

1

EXTN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 59 industry peers in the Energy Equipment & Services industry. EXTN may be in some trouble as it scores bad on both profitability and health. EXTN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EXTN had negative earnings in the past year.
In the past year EXTN had a positive cash flow from operations.
EXTN Yearly Net Income VS EBIT VS OCF VS FCFEXTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M -100M 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA -6.56%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXTN Yearly ROA, ROE, ROICEXTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -20 -40 -60

1.3 Margins

Industry RankSector Rank
OM -0.45%
PM (TTM) -11.16%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EXTN Yearly Profit, Operating, Gross MarginsEXTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40

More info and screens

1

2. Health

2.1 Basic Checks

EXTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
EXTN has more shares outstanding than it did 1 year ago.
The debt/assets ratio for EXTN is higher compared to a year ago.
EXTN Yearly Shares OutstandingEXTN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
EXTN Yearly Total Debt VS Total AssetsEXTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

2.2 Solvency

EXTN has an Altman-Z score of 0.13. This is a bad value and indicates that EXTN is not financially healthy and even has some risk of bankruptcy.
EXTN has a Debt/Equity ratio of 4.65. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 4.65
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC8.73%
EXTN Yearly LT Debt VS Equity VS FCFEXTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M

2.3 Liquidity

EXTN has a Current Ratio of 1.29. This is a normal value and indicates that EXTN is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.05 indicates that EXTN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.05
EXTN Yearly Current Assets VS Current LiabilitesEXTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

EXTN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.62%, which is quite impressive.
Looking at the last year, EXTN shows a very strong growth in Revenue. The Revenue has grown by 26.06%.
The Revenue has been decreasing by -6.99% on average over the past years.
EPS 1Y (TTM)20.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.7%
Revenue 1Y (TTM)26.06%
Revenue growth 3Y-22.63%
Revenue growth 5Y-6.99%
Sales Q2Q%51.35%

3.2 Future

Based on estimates for the next years, EXTN will show a small growth in Earnings Per Share. The EPS will grow by 0.59% on average per year.
EXTN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.28% yearly.
EPS Next Y-6.04%
EPS Next 2Y11.47%
EPS Next 3Y3.16%
EPS Next 5Y0.59%
Revenue Next Year42.26%
Revenue Next 2Y24.76%
Revenue Next 3Y12.67%
Revenue Next 5Y7.28%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXTN Yearly Revenue VS EstimatesEXTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
EXTN Yearly EPS VS EstimatesEXTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

EXTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EXTN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EXTN Price Earnings VS Forward Price EarningsEXTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.81
EXTN Per share dataEXTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.47%
EPS Next 3Y3.16%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EXTN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Exterran Corporation

NYSE:EXTN (10/12/2022, 8:14:15 PM)

After market: 4.66 +0.08 (+1.75%)

4.58

-0.26 (-5.37%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-09 2022-08-09/bmo
Earnings (Next)11-01 2022-11-01/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners1.06%
Ins Owner Change0%
Market Cap153.41M
Analysts82.86
Price Target9.69 (111.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.09%
Min EPS beat(2)-148.37%
Max EPS beat(2)72.18%
EPS beat(4)2
Avg EPS beat(4)-49.95%
Min EPS beat(4)-166.54%
Max EPS beat(4)72.18%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.1%
Min Revenue beat(2)-3.62%
Max Revenue beat(2)5.82%
Revenue beat(4)1
Avg Revenue beat(4)-3.1%
Min Revenue beat(4)-8.7%
Max Revenue beat(4)5.82%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF 38.77
P/B 1.04
P/tB 1.73
EV/EBITDA 4.81
EPS(TTM)-2.31
EYN/A
EPS(NY)-2.29
Fwd EYN/A
FCF(TTM)-2.6
FCFYN/A
OCF(TTM)0.12
OCFY2.58%
SpS22.72
BVpS4.39
TBVpS2.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.56%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.45%
PM (TTM) -11.16%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 4.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.44%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 102.45%
Current Ratio 1.29
Quick Ratio 1.05
Altman-Z 0.13
F-Score5
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.7%
EPS Next Y-6.04%
EPS Next 2Y11.47%
EPS Next 3Y3.16%
EPS Next 5Y0.59%
Revenue 1Y (TTM)26.06%
Revenue growth 3Y-22.63%
Revenue growth 5Y-6.99%
Sales Q2Q%51.35%
Revenue Next Year42.26%
Revenue Next 2Y24.76%
Revenue Next 3Y12.67%
Revenue Next 5Y7.28%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1350.17%
FCF growth 3YN/A
FCF growth 5Y-50.27%
OCF growth 1Y-96.14%
OCF growth 3Y-33.95%
OCF growth 5Y-29.67%